AdaptHealth (AHCO) EBT Growth (3y) (2021 - 2026)
AdaptHealth (AHCO) EBT Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 5.75% |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn | 4.82% |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn | -2.57% |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn | 61.06% |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn | 32.11% |
| 10 | AdaptHealth | 1.48 Bn | 1.43 Bn | 111.50 Mn | -49.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.54% |
| Dec 31, 2025 | -220.72% |
| Sep 30, 2025 | 16.81% |
| Jun 30, 2025 | 28.99% |
| Mar 31, 2025 | -28.25% |
| Dec 31, 2024 | 28.28% |
| Sep 30, 2024 | -23.09% |
| Jun 30, 2024 | -33.01% |
| Mar 31, 2024 | 44.72% |
| Dec 31, 2023 | -40.61% |
| Sep 30, 2023 | -93.87% |
| Jun 30, 2023 | 28.28% |
| Mar 31, 2023 | 31.86% |
| Dec 31, 2022 | 29.77% |
| Sep 30, 2022 | 136.48% |
| Jun 30, 2022 | 343.65% |
| Mar 31, 2022 | 160.94% |
| Dec 31, 2021 | 18.24% |
| Sep 30, 2021 | 352.48% |
| Jun 30, 2021 | 364.43% |